Systematic review of definitions used in clinical trials for people with Cystic Fibrosis and chronic / persistent Pseudomonas infection.

Systematic review of definitions used in clinical trials for people with Cystic Fibrosis and chronic / persistent Pseudomonas infection.

 

Type of service

Dissertation services

Type of assignment

Dissertation

Subject

Healthcare&Medicine

Pages / words

37 / 10000

Academic level

Master’s

Paper format

Harvard

Line spacing

Double

Language style

UK English

Additional features

Draft required

A part of your paper to report on the progress

Description

The aim of this review is to identify what definitions are being used in clinical drug trials for Pseudomonas in Cystic Fibrosis patients.

We are not aiming to devise a protocol for defining Pseudomonas, because there are already lots of protocols out there.
What we want is just to understand the frequency at which the current definitions are used (if at all) within RCTs in CF. Then the conclusion/future research section can include ‘there should be a universally used protocol developed and implemented’.

I am also sending you my proposal which I did in June 2019, please have a look and contact me any time if needed.